AI-Powered Medical Devices for Heart Disease Delivered via Cloud Platforms

**1. ** CLEERLY (CLEERLY HEALTH)

• Focus: AI-based coronary artery disease (CAD) analysis using CT angiography.
• Cloud AI: Cloud-powered AI analyzes plaque morphology and ischemia risk.
• Key Feature: Provides a personalized atherosclerosis roadmap for treatment planning.

**2. ** ECHOGO (ULTROMICS)

• Focus: AI-driven echocardiography analysis for heart failure, CAD, and valvular disease.
• Cloud AI: Cloud platform that automates parts of echocardiogram analysis; several EchoGo products have FDA clearance (check the FDA database for each indication).
• Key Feature: Designed to identify patterns that can be difficult to see by eye, supporting cardiologists' interpretation.

**3. ** CARDIOLOGS (A PHILIPS COMPANY)

• Focus: AI for ECG and arrhythmia detection (e.g., AFib, PVCs).
• Cloud AI: Cloud-based AI analyzes ECGs in real time, integrating with wearables.
• Key Feature: Used in telemedicine for remote cardiac monitoring.

**4. ** AIDOC CARDIOVASCULAR

• Focus: AI for detecting acute cardiovascular conditions (e.g., pulmonary embolism, aortic dissection) in imaging.
• Cloud AI: Cloud-based radiology AI that flags critical findings in CT/MRI.
• Key Feature: Prioritizes urgent cases for faster intervention.

**5. ** CAPTION HEALTH (FORMERLY BAY LABS, ACQUIRED BY GE HEALTHCARE IN 2023)

• Focus: AI guidance for echocardiography image acquisition.
• Cloud AI: Deep learning models for image guidance and automated ejection fraction estimation.
• Key Feature: Enhances point-of-care ultrasound (POCUS) diagnostics.

Bonus: Emerging AI Platforms

• ALIVECOR (KARDIAAI) – AI for mobile ECG detection of arrhythmias.

AliveCor (KardiaAI) uses cloud infrastructure to power its AI-driven mobile ECG and arrhythmia detection platform.

Key Details:

1. Devices: AI processes ECGs from KardiaMobile devices (1L/6L).

2. AI Workflow:

o Users record ECGs via KardiaMobile or KardiaApp.

o Data is sent to the cloud, where AI flags possible AFib, bradycardia, tachycardia, and other rhythm findings for review.

o Results are delivered to users via the app and can be shared with clinicians.

3. Regulatory:

o Several KardiaMobile devices and Kardia AI determinations have FDA clearance; check the FDA 510(k) database for the cleared indications.

• HEARTFLOW (FFR-CT AI) – Cloud-based CT-derived fractional flow reserve for ischemia assessment.

These platforms leverage cloud AI to improve diagnosis, risk stratification, and treatment decisions in cardiology, always as support for clinicians.